Classifying Ectopia Lentis in Marfan Syndrome Into Five Grades of Increasing Severity

Marfan Syndrome Clinical Trial

Official title:

Classifying Ectopia Lentis in Marfan Syndrome Into Five Grades of Increasing Severity

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04319107
• Other study ID #: MARFAN_2020
• Status: Completed
• Start date: January 1, 2000
• Est. completion date: December 31, 2013

Study information

• Verified date: March 2020
• Source: Hospices Civils de Lyon
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Marfan syndrome is characterized by musculoskeletal manifestations, cardiovascular disease and ocular abnormalities, particularly ectopia lentis. Diagnosis depends on clinical evaluation, family history and molecular data: mutation in the fibrillin-1 gene (FBN1). Ectopia lentis is the most common ocular manifestation in Marfan syndrome with FBN1 mutation and is relatively specific to this disease when associated with other features. However, clinical examinations for identifying ectopia lentis have not really been codified. The purpose of this study is to describe a 5-grade classification of increasing severity for ectopia lentis based on clinical examination and to evaluate the predictive value for the early grades of ectopia lentis in order to help characterize this major clinical diagnosis criterion.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 110
• Est. completion date: December 31, 2013
• Est. primary completion date: December 31, 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• MFS patient, clinical diagnosis according to revised Ghent criteria, confirmed by FBN1 mutation.

• Relatives of MFS patients with none of the clinical features of MFS and in whom testing for the familial FBN1 mutation was negative.

Exclusion Criteria:

• Patients who had surgery for ectopia lentis

• Patients for whom dilation was not optimal.

Related Conditions & MeSH terms

• Ectopia Lentis
• Marfan Syndrome
• Syndrome

Intervention

Other:
• ophthalmological examinations using a slit lamp bio microscopy and a three-mirror lens, standard procedure.
Pupillary dilatation was performed with instillation of tropicamide and phenylephrine. The ophthalmological examination included visual acuity measurement, using a slit lamp biomicroscopy to analyse the anterior segment and a three mirror lens to appreciate the quality of the dilation validated by the absence of pupillary reflex and to search for ectopia lentis. Ectopia Lentis grade is evaluated according to the 5-grade classification.

Locations

Country	Name	City	State
France	Hopital Femme Mère Enfant	Bron

Sponsors (1)

Lead Sponsor	Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

References & Publications (1)

Zech JC, Putoux A, Decullier E, Fargeton AE, Edery P, Plauchu H, Dupuis-Girod S. Classifying Ectopia Lentis in Marfan Syndrome into Five Grades of Increasing Severity. J Clin Med. 2020 Mar 6;9(3). pii: E721. doi: 10.3390/jcm9030721. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Ectopia lentis measurement	Ectopia lentis measurement and classification into 5-stages. Evaluation of the predictive value of ectopia lentis, at early stages, in order to help characterize this major clinical diagnosis criteria.	day 0